Clinical Trial Details
— Status: Recruiting
Administrative data
| NCT number |
NCT05325710 |
| Other study ID # |
2021-A00375-36 |
| Secondary ID |
|
| Status |
Recruiting |
| Phase |
N/A
|
| First received |
|
| Last updated |
|
| Start date |
March 20, 2022 |
| Est. completion date |
April 1, 2028 |
Study information
| Verified date |
March 2022 |
| Source |
Ramsay Générale de Santé |
| Contact |
JF OUDET |
| Phone |
068346567 |
| Email |
jf.oudet[@]ecten.eu |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Interventional
|
Clinical Trial Summary
In France, the overall prevalence of diabetes was estimated at 5% of population in 2016, type
2 diabetes (T2DM) corresponding to 90% of cases. However, this figure is greatly
underestimated,since it does not take into account people who are untreated or not diagnosed.
However,it is estimated that 20 to 30% of adults with diabetes do not are not diagnosed.
Conclusions presented during the annual meeting of the european Association for the Study of
diabetes (EASD-Berlin) from 2019 suggest that signs precursors of the disease would be
present up to 20 years before the diagnosis.
The Diagnosis is usually made around 40-50 years. The main factor of risk of T2D is the
lifestyle, in particular a diet too rich for a too sedentary daily life.
From a medico-economic point of view, chronic pathologies (including diabetes) account for
60% of insurance expenditure illness even though they concern 35% of insured persons, i.e. 20
million patients. The average annual repayment of a type 2 diabetic patient is 4890 euros.
This study is part of this context as the starting point a reflection on a different,
coordinated management, to know a preventive rather than a curative approach.
Description:
In France, the overall prevalence of diabetes was estimated at 5% of population in 2016, type
2 diabetes (T2DM) corresponding to 90% of cases. However, this figure is greatly
underestimated. since it does not take into account people who are untreated or not
diagnosed. However, given the silent nature of the disease, it is estimated that 20 to 30% of
adults with diabetes do not are not diagnosed. This share decreases with age, falling to 13%
among 55-74 year olds. Conclusions presented during the annual meeting of the european
Association for the Study of diabetes (EASD-Berlin) from 2019 suggest that signs precursors
of the disease would be present up to 20 years before the diagnosis.
Type 2 diabetes, or non-insulin dependent diabetes, is a metabolic disease characterized by a
chronic excess of sugar in the blood, affecting both men and women. the Diagnosis is usually
made around 40-50 years. The main factor of risk of T2D is the lifestyle, in particular a
diet too rich for a too sedentary daily life. The direct consequences are an increase in
obesity hich is itself a major risk factor for the development of T2D. Among the risk
factors, we also find hyperlipidemia, high blood pressure, high blood sugar fasting, stress,
smoking, heredity, family history of diabetes, or gestational diabetes.
From a medico-economic point of view, chronic pathologies (including diabetes) account for
60% of insurance expenditure illness even though they concern 35% of insured persons, i.e. 20
million patients. The average annual repayment of a type 2 diabetic patient is 4890
euros.This study is part of this context as the starting point a reflection on a different,
coordinated management, to know a preventive rather than a curative approach.
